Literature DB >> 6378794

Phenotypic distinctiveness of Staphylococcus aureus strains associated with toxic shock syndrome.

J K Todd, A Franco-Buff, D W Lawellin, M L Vasil.   

Abstract

Twenty Staphylococcus aureus strains from patients with toxic shock syndrome (TSS) and 20 from control patients (non-TSS) with infection but no clinical evidence of TSS were compared phenotypically in a collaborative, blinded, randomized study. TSS strains were significantly (P less than 0.05) more likely than non-TSS strains to produce various previously described but related toxic shock-associated proteins (pyrogenic exotoxin C, enterotoxin F, and TSS marker protein), as well as differing in other distinctive phenotypic characteristics, such as hemolysis, bacteriocin susceptibility, arsenate resistance, pigment production, and casein proteolysis. TSS strains were significantly less likely to carry plasmids than control strains. A combination of two variables--proteolysis and toxic shock-associated protein production--statistically accounted for all other phenotypic variations between TSS and non-TSS strains. Only proteolysis covaried with all other significant variables, suggesting a primary role in the phenotypic distinctiveness of TSS S. aureus strains and possibly in the pathogenesis of TSS.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6378794      PMCID: PMC263226          DOI: 10.1128/iai.45.2.339-344.1984

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  24 in total

1.  Isolation and composition of staphylococcal alpha toxin.

Authors:  A W BERNHEIMER; L L SCHWARTZ
Journal:  J Gen Microbiol       Date:  1963-03

2.  Typing of coagulase-positive staphylococci by proteolytic activity on buffered caseinate-agar, with special reference to bacteriophage nontypable strains.

Authors:  F G Martley; A W Jarvis; D F Bacon; R C Lawrence
Journal:  Infect Immun       Date:  1970-10       Impact factor: 3.441

3.  Metachromatic agar-diffusion methods for detecting staphylococcal nuclease activity.

Authors:  R V Lachica; C Genigeorgis; P D Hoeprich
Journal:  Appl Microbiol       Date:  1971-04

4.  The toxic shock syndrome exotoxin structural gene is not detectably transmitted by a prophage.

Authors:  B N Kreiswirth; S Löfdahl; M J Betley; M O'Reilly; P M Schlievert; M S Bergdoll; R P Novick
Journal:  Nature       Date:  1983 Oct 20-26       Impact factor: 49.962

5.  Epidermal toxin production by Staphylococcus aureus strains from patients with toxic shock syndrome.

Authors:  F A Kapral
Journal:  Ann Intern Med       Date:  1982-06       Impact factor: 25.391

6.  Detecting the enterotoxigenicity of Staphylococcus aureus strains.

Authors:  R Robbins; S Gould; M Bergdoll
Journal:  Appl Microbiol       Date:  1974-12

7.  A new staphylococcal enterotoxin, enterotoxin F, associated with toxic-shock-syndrome Staphylococcus aureus isolates.

Authors:  M S Bergdoll; B A Crass; R F Reiser; R N Robbins; J P Davis
Journal:  Lancet       Date:  1981-05-09       Impact factor: 79.321

8.  Toxic-shock syndrome associated with phage-group-I Staphylococci.

Authors:  J Todd; M Fishaut; F Kapral; T Welch
Journal:  Lancet       Date:  1978-11-25       Impact factor: 79.321

9.  Protein antigens from Staphylococcus aureus strains associated with toxic-shock syndrome.

Authors:  M L Cohen; S Falkow
Journal:  Science       Date:  1981-02-20       Impact factor: 47.728

10.  Staphylococcus aureus associated with toxic shock syndrome: phage typing and toxin capability testing.

Authors:  W A Altemeier; S A Lewis; P M Schlievert; M S Bergdoll; H S Bjornson; J L Staneck; B A Crass
Journal:  Ann Intern Med       Date:  1982-06       Impact factor: 25.391

View more
  13 in total

Review 1.  Superantigens related to Kawasaki syndrome.

Authors:  D Y Leung
Journal:  Springer Semin Immunopathol       Date:  1996

2.  Production of gamma-hemolysin and lack of production of alpha-hemolysin by Staphylococcus aureus strains associated with toxic shock syndrome.

Authors:  M Clyne; J De Azavedo; E Carlson; J Arbuthnott
Journal:  J Clin Microbiol       Date:  1988-03       Impact factor: 5.948

3.  Characterization of clinical strains of Staphylococcus aureus associated with pneumonia.

Authors:  B A Sanford; V L Thomas; M A Ramsay; T O Jones
Journal:  J Clin Microbiol       Date:  1986-07       Impact factor: 5.948

4.  Characterization of staphylococci from patients with toxic shock syndrome.

Authors:  B Aliu; M S Bergdoll
Journal:  J Clin Microbiol       Date:  1988-11       Impact factor: 5.948

Review 5.  Toxic shock syndrome.

Authors:  J K Todd
Journal:  Clin Microbiol Rev       Date:  1988-10       Impact factor: 26.132

6.  Association of toxic shock toxin-1 determinant with a heterologous insertion at multiple loci in the Staphylococcus aureus chromosome.

Authors:  M C Chu; B N Kreiswirth; P A Pattee; R P Novick; M E Melish; J F James
Journal:  Infect Immun       Date:  1988-10       Impact factor: 3.441

7.  Toxic shock syndrome.

Authors:  R Buchdahl; M Levin; B Wilkins; J Gould; P Jaffe; D J Matthew; M J Dillon
Journal:  Arch Dis Child       Date:  1985-06       Impact factor: 3.791

8.  Regulation of staphylococcal toxic shock syndrome toxin-1 and total exoprotein production by magnesium ion.

Authors:  J T Mills; A W Dodel; E H Kass
Journal:  Infect Immun       Date:  1986-09       Impact factor: 3.441

9.  Streptococcus associated toxic shock.

Authors:  C Torres-Martínez; D Mehta; A Butt; M Levin
Journal:  Arch Dis Child       Date:  1992-01       Impact factor: 3.791

Review 10.  Syndromes with renal failure and shock.

Authors:  M Levin
Journal:  Pediatr Nephrol       Date:  1994-04       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.